Riskpilot← Back to searchSign inGet full accessPsilox AB
ABActiveOrg 5569331928Vallvägen 4 A 1trManufacture of medical and dental instruments and supplies · NACE 3250Est. 20131-4 employees
Revenue 2024
SEK 65K
-10% vs 2023
EBITDA margin
-6952.3%
+5% vs 2023
Equity ratio
25.9%
Financial strength
Net profit 2024
SEK -5,2M
+2% vs 2023
| Revenue | SEK 65K | -10% |
| EBITDA | SEK -4,5M | +5% |
| Net profit | SEK -5,2M | +2% |
| Total assets | SEK 2,9M | -47% |
| Equity | SEK 752K | -78% |
| Employees | — | — |
Legal name
Psilox AB
Org number
5569331928
Legal form
Aktiebolag
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
29 maj 2013
Share capital
SEK 529 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska på kommersiella grunder bedriva forskning, utveckling, tillverkning och marknadsföring av kvalificerade produkter och tjänster inom området biomaterial och därmed förenlig verksamhet.
Address
Vallvägen 4 A 1tr
Email
tomas.lindstrom@psilox.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 317 | 751 | 552 | 1 807 | 872 | 72 | 65 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −1 659 | −2 245 | −2 812 | −3 953 | −4 659 | −5 676 | −5 770 | −8 395 | −4 736 | −4 519 |
| Depreciation & amort. | −7 | −30 | −31 | −34 | −38 | −146 | −449 | −603 | −604 | −606 |
| EBIT | −1 666 | −2 275 | −2 843 | −3 987 | −4 697 | −5 822 | −6 219 | −8 998 | −5 340 | −5 125 |
| Net financials | — | — | — | — | — | — | −55 | −65 | 16 | −96 |
| Profit before tax | −1 665 | −2 275 | −2 844 | −3 987 | −4 697 | −5 822 | −6 274 | −9 063 | −5 324 | −5 221 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −1 665 | −2 275 | −2 844 | −3 987 | −4 697 | −5 822 | −6 274 | −9 063 | −5 324 | −5 221 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 715 | 4 638 | 6 791 | 5 445 | 12 734 | 8 484 | 14 150 | 9 706 | 5 440 | 2 906 |
| Equity | 1 476 | 4 056 | 5 795 | 4 473 | 11 896 | 6 074 | 10 786 | 7 027 | 3 370 | 752 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 1 667 | 1 125 | 1 125 | 1 250 |
| Short-term debt | 239 | 582 | 997 | 973 | 839 | 2 411 | 1 698 | 1 554 | 944 | 904 |
| Total debt | 239 | 582 | 997 | 973 | 839 | 2 411 | 3 365 | 2 679 | 2 069 | 2 154 |
EBITDA margin
-6952.3%
This company
15.8%
Market median
-44102% vs market
20152024
Equity ratio
25.9%
This company
38.2%
Market median
-32% vs market
20152024
Return on equity
-694.3%
This company
18.4%
Market median
-3873% vs market
20152024
Net profit margin
-8032.3%
This company
8.1%
Market median
-99264% vs market
20152024
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20152024
Debt / equity
2.86×
This company
0.62×
Market median
-361% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CV Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
HT Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
LG Chief Auditor | Chief Auditor | 2022 | — | — |
BN Chief Auditor | Chief Auditor | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2025 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Psilox AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carin Viola Christina Forsström | Chief Executive Officer | 0 companies |
| Hans Tomas Lindström | Chief Executive Officer | 0 companies |
| Lars Gustaf Kylberg | Chief Auditor | 0 companies |
| Bengt Nils Martin Holm | Chief Auditor | 0 companies |
| Håkan Gunnar Engqvist | Chairman | 0 companies |
| Thomas Pollare | Board of Directors | 0 companies |
| Per Jesper Dahlberg | Board of Directors | 0 companies |
| Kjell Edmund Kullander | Board of Directors | 0 companies |
| Carani Balarman Sanjeevi | Board of Directors | 0 companies |